Schonfeld Strategic Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $970K | Sell |
10,029
-23,272
| -70% | -$2.39M | 0.01% | 1112 |
|
|
2025
Q4 | $3.53M | Sell |
33,301
-27,212
| -45% | -$3.15M | 0.02% | 672 |
|
|
2025
Q3 | $7.69M | Buy |
60,513
+18,200
| +43% | +$2.17M | 0.04% | 426 |
|
|
2025
Q2 | $5.19M | Buy |
42,313
+28,113
| +198% | +$3.21M | 0.04% | 553 |
|
|
2025
Q1 | $1.44M | Sell |
14,200
-17,860
| -56% | -$1.74M | 0.01% | 1129 |
|
|
2024
Q4 | $2.96M | Buy |
32,060
+29,149
| +1,001% | +$2.86M | 0.02% | 682 |
|
|
2024
Q3 | $281K | Sell |
2,911
-17,249
| -86% | -$1.55M | ﹤0.01% | 1682 |
|
|
2024
Q2 | $1.73M | Buy |
+20,160
| New | +$1.69M | 0.01% | 969 |
|
|
2024
Q1 | – | Sell |
-3,740
| Closed | -$250K | – | 2149 |
|
|
2023
Q4 | $250K | Buy |
+3,740
| New | +$242K | ﹤0.01% | 1481 |
|
|
2023
Q3 | – | Sell |
-3,518
| Closed | -$238K | – | 1897 |
|
|
2023
Q2 | $238K | Sell |
3,518
-13,187
| -79% | -$826K | ﹤0.01% | 1493 |
|
|
2023
Q1 | $904K | Buy |
+16,705
| New | +$972K | 0.01% | 994 |
|
|
2022
Q4 | – | Sell |
-17,566
| Closed | -$795K | – | 2687 |
|
|
2022
Q3 | $795K | Sell |
17,566
-17,181
| -49% | -$860K | 0.01% | 1440 |
|
|
2022
Q2 | $1.55M | Buy |
34,747
+1,225
| +4% | +$62.8K | 0.02% | 832 |
|
|
2022
Q1 | $1.9M | Buy |
33,522
+8,748
| +35% | +$457K | 0.02% | 753 |
|
|
2021
Q4 | $1.29M | Sell |
24,774
-87,592
| -78% | -$4.52M | 0.01% | 822 |
|
|
2021
Q3 | $6.71M | Buy |
112,366
+32,007
| +40% | +$2.01M | 0.07% | 358 |
|
|
2021
Q2 | $4.99M | Buy |
80,359
+43,833
| +120% | +$2.92M | 0.05% | 460 |
|
|
2021
Q1 | $2.38M | Buy |
36,526
+27,154
| +290% | +$1.77M | 0.03% | 619 |
|
|
2020
Q4 | $616K | Buy |
+9,372
| New | +$551K | 0.01% | 974 |
|
|
2020
Q1 | – | Sell |
-12,903
| Closed | -$711K | – | 1231 |
|
|
2019
Q4 | $711K | Buy |
12,903
+533
| +4% | +$28.9K | 0.02% | 612 |
|
|
2019
Q3 | $623K | Sell |
12,370
-3,720
| -23% | -$187K | 0.02% | 588 |
|
|
2019
Q2 | $811K | Buy |
16,090
+1,760
| +12% | +$85.4K | 0.03% | 501 |
|
|
2019
Q1 | $666K | Sell |
14,330
-10,433
| -42% | -$529K | 0.02% | 615 |
|
|
2018
Q4 | $1.22M | Buy |
24,763
+10,433
| +73% | +$593K | 0.05% | 431 |
|
|
2018
Q3 | $889K | Buy |
14,330
+7,530
| +111% | +$458K | 0.04% | 451 |
|
|
2018
Q2 | $366K | Buy |
+6,800
| New | +$340K | 0.02% | 593 |
|
|
2018
Q1 | – | Sell |
-11,098
| Closed | -$436K | – | 814 |
|
|
2017
Q4 | $436K | Buy |
+11,098
| New | +$422K | 0.04% | 494 |
|
Other funds holding EHC
VPM
VCM
Schonfeld Strategic Advisors's EHC Position: Q1 2026 in Review
Schonfeld Strategic Advisors reduced its Encompass Health (EHC) stake by 70% in Q1 2026, selling an estimated $2.39M and leaving 10,029 shares worth $970K. The position accounts for 0.01% of the portfolio, ranked #1112.
Schonfeld Strategic Advisors first reported a position in EHC in Q4 2017 and has held it in 27 quarters since. The position peaked at $7.69M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Schonfeld Strategic Advisors held 10,029 shares of Encompass Health worth $970K as of Q1 2026.
- Schonfeld Strategic Advisors sold 23,272 Encompass Health shares in Q1 2026, an estimated $2.39M.
- Encompass Health made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1112 holding.
- Schonfeld Strategic Advisors first reported a position in Encompass Health in Q4 2017 and has held it in 27 quarters since.
- Schonfeld Strategic Advisors's Encompass Health position peaked at $7.69M in Q3 2025.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.